Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nat Commun. 2014;4:4999.
Ghoussaini M, Edwards SL, Michailidou K et al.
MicroRNA Related Polymorphisms and Breast Cancer Risk. PLoS One. 2014; 9(11):e109973.
Khan S, Greco D, Michailidou K et al.
Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium. Hum Mol Genet. 2014;23(22):6096-111.
Milne RL, Burwinkel B, Michailidou K et al.
Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study. Breast Cancer Research. 2014; 16(3):R51.
Johnson N, Dudbridge F, Orr N et al.
The relationship between obesity and exposure to light at night: cross-sectional analyses of over 100,000 women in the Breakthrough Generations Study. Am J Epidemiol. 2014; 180(3):245-50.
McFadden E, Jones ME, Schoemaker MJ, Ashworth A, Swerdlow AJ.
Genetic predisposition to in situ and invasive lobular carcinoma of the breast. PloS Genet. 2014; 10(4):e1004285.
Sawyer E, Roylance R, Petridis C et al.
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium. Br J Cancer. 2014; 110(4):1088-100.
Agarwal D, Pineda S, Michailidou K et al.
Reproducibility of Estradiol and Testosterone Levels in Postmenopausal Women Over 5 Years: Results from the Breakthrough Generations Study. Am J Epidemiol. 2014;179(9):1128-33.
Jones ME, Schoemaker MJ, Rae M, Folkerd EJ, Dowsett M, Ashworth A, Swerdlow AJ.
Combined effects of endogenous sex hormone levels and mammographic density on postmenopausal breast cancer risk: results from the Breakthrough Generations Study. Br J Cancer. 2014;110(7):1898-907.
Schoemaker MJ, Folkerd EJ, Jones ME, Rae M, Allen S, Ashworth A, Dowsett M, Swerdlow AJ.
Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study. Breast Cancer Res. 2014;16:R18.
Bodicoat DH, Schoemaker MJ, Jones ME, McFadden E, Griffin J, Ashworth A, Swerdlow AJ.
